Primary Analysis of the SYMPATICO trial in Mantle Cell Lymph

Focusing on mantle cell lymphoma, Lori A. Leslie, MD, reviews the primary analysis of the SYMPATICO trial investigating ibrutinib-venetoclax combination therapy.

Related Keywords

Lori Leslie , Jamesk Mccloskey , Gloria Leslie , Hackensack University Medical Center , John Theurer Cancer Center , Research Programs , Peer Exchange , Hackensack University Medical , Associate Professor , Indolent Lymphoma , While Bruton , Lymphoma , Mash 2023 , Sympatico Study , Sympatico Trial , Mantle Cell Lymphoma , Btk Inhibitors , Venetoclax , Ibrutinib , Combination Therapy ,